These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4119160)

  • 1. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.
    Plow E; Edgington TS
    J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments.
    Plow EF; Edgington TS
    J Clin Invest; 1975 Dec; 56(6):1509-18. PubMed ID: 53241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating neoantigenic differences between fibrinogen and fibrin derivatives.
    Plow EF; Edgington TS
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1169-73. PubMed ID: 4123931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular events responsible for modulation of neoantigenic expression: the cleavage-associated neoantigen of fibrinogen (blood coagulation-fibrinogen cleavage products-fibrinolysis-molecular conformation).
    Plow E; Edgington TS
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):208-12. PubMed ID: 4109598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cleavage-associated neoantigenic marker for a gamma chain site in the NH2-terminal aspect of the fibrinogen molecule.
    Plow EF; Edgington TS
    J Biol Chem; 1975 May; 250(9):3386-92. PubMed ID: 47327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoantigenic expressions engendered by plasmin cleavage of fibrinogen.
    Plow EF; Hougie C; Edgington TS
    J Immunol; 1971 Nov; 107(5):1496-500. PubMed ID: 4107365
    [No Abstract]   [Full Text] [Related]  

  • 7. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
    Stegnar M; Chen JP
    Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational and structural modulation of the NH2-terminal regions of fibrinogen and fibrin associated with plasmin cleavage.
    Edgington TS; Plow EF
    J Biol Chem; 1975 May; 250(9):3393-8. PubMed ID: 47328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number of D and E regions in the fibrinogen molecule.
    Plow EF; Edgington TS
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):158-62. PubMed ID: 4129800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.
    Plow EF; Edgington TS
    J Clin Invest; 1975 Jul; 56(1):30-8. PubMed ID: 237938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation pathway of fibrinogen by plasmin.
    Budzynski AZ; Marder VJ
    Thromb Haemost; 1977 Dec; 38(4):793-800. PubMed ID: 146273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical discrimination of leukocyte elastase from plasmic degradation products of fibrinogen.
    Plow EF; Gramse M; Havemann K
    J Lab Clin Med; 1983 Dec; 102(6):858-69. PubMed ID: 6227673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding.
    Dejana E; Languino LR; Polentarutti N; Balconi G; Ryckewaert JJ; Larrieu MJ; Donati MB; Mantovani A; Marguerie G
    J Clin Invest; 1985 Jan; 75(1):11-8. PubMed ID: 3965498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
    Chi DS; Chen JP
    Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoelectrophoretic studies on the kinetics of plasmic degradation of human fibrinogen.
    Braude R; Altman R; Rouvier J; Aguilar N
    Thromb Haemost; 1977 Feb; 37(1):136-43. PubMed ID: 576511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM-40) binds to fibrinogen fragments D and E, but not to native fibrinogen.
    Wang H; Workman G; Chen S; Barker TH; Ratner BD; Sage EH; Jiang S
    Matrix Biol; 2006 Jan; 25(1):20-6. PubMed ID: 16263253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a specific antibody population against human fibrinogen.
    Lau HK; Cheung M; Siu A
    Biochem Int; 1987 Sep; 15(3):561-9. PubMed ID: 2447894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
    Iio A; Rutherford WE; Wochner RD; Spilberg I; Sherman LA
    J Lab Clin Med; 1976 Jun; 87(6):934-46. PubMed ID: 932524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic identification of the cleavage products from the A alpha- and B beta-chains in the early stages of plasmin digestion of fibrinogen.
    Liu CY; Sobel JH; Weitz JI; Kaplan KL; Nossel HL
    Thromb Haemost; 1986 Aug; 56(1):100-6. PubMed ID: 2946092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.